Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Insomnia Medication Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Nonbenzodiazepine Receptor Agonists
  • 1.3.3 Benzodiazepine Receptor Agonists
  • 1.3.4 The Selective Melatonin Receptor Agonist Ramelteon
  • 1.3.5 Sedating Antidepressants
• 1.4 Market Segment by Application
  • 1.4.1 Global Insomnia Medication Market Share by Application (2019-2025)
  • 1.4.2 Adults
  • 1.4.3 Kids
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Insomnia Medication Market Size
  • 2.1.1 Global Insomnia Medication Revenue 2014-2025
  • 2.1.2 Global Insomnia Medication Sales 2014-2025
• 2.2 Insomnia Medication Growth Rate by Regions
  • 2.2.1 Global Insomnia Medication Sales by Regions 2014-2019
  • 2.2.2 Global Insomnia Medication Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Insomnia Medication Sales by Manufacturers
  • 3.1.1 Insomnia Medication Sales by Manufacturers 2014-2019
  • 3.1.2 Insomnia Medication Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Insomnia Medication Revenue by Manufacturers (2014-2019)
  • 3.2.2 Insomnia Medication Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Insomnia Medication Market Concentration Ratio (CR5 and HHI)
• 3.3 Insomnia Medication Price by Manufacturers
• 3.4 Key Manufacturers Insomnia Medication Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Insomnia Medication Market
• 3.6 Key Manufacturers Insomnia Medication Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Nonbenzodiazepine Receptor Agonists Sales and Revenue (2014-2019)
  • 4.1.2 Benzodiazepine Receptor Agonists Sales and Revenue (2014-2019)
  • 4.1.3 The Selective Melatonin Receptor Agonist Ramelteon Sales and Revenue (2014-2019)
  • 4.1.4 Sedating Antidepressants Sales and Revenue (2014-2019)
• 4.2 Global Insomnia Medication Sales Market Share by Type
• 4.3 Global Insomnia Medication Revenue Market Share by Type
• 4.4 Insomnia Medication Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Insomnia Medication Sales by Application

6 United States

• 6.1 United States Insomnia Medication Breakdown Data by Company
• 6.2 United States Insomnia Medication Breakdown Data by Type
• 6.3 United States Insomnia Medication Breakdown Data by Application

7 European Union

• 7.1 European Union Insomnia Medication Breakdown Data by Company
• 7.2 European Union Insomnia Medication Breakdown Data by Type
• 7.3 European Union Insomnia Medication Breakdown Data by Application

8 China

• 8.1 China Insomnia Medication Breakdown Data by Company
• 8.2 China Insomnia Medication Breakdown Data by Type
• 8.3 China Insomnia Medication Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Insomnia Medication Breakdown Data by Company
• 9.2 Rest of World Insomnia Medication Breakdown Data by Type
• 9.3 Rest of World Insomnia Medication Breakdown Data by Application
• 9.4 Rest of World Insomnia Medication Breakdown Data by Countries
  • 9.4.1 Rest of World Insomnia Medication Sales by Countries
  • 9.4.2 Rest of World Insomnia Medication Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Eisai
  • 10.1.1 Eisai Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.1.4 Insomnia Medication Product Introduction
  • 10.1.5 Eisai Recent Development
• 10.2 Merck
  • 10.2.1 Merck Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.2.4 Insomnia Medication Product Introduction
  • 10.2.5 Merck Recent Development
• 10.3 Pfizer
  • 10.3.1 Pfizer Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.3.4 Insomnia Medication Product Introduction
  • 10.3.5 Pfizer Recent Development
• 10.4 Sanofi
  • 10.4.1 Sanofi Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.4.4 Insomnia Medication Product Introduction
  • 10.4.5 Sanofi Recent Development
• 10.5 Takeda
  • 10.5.1 Takeda Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.5.4 Insomnia Medication Product Introduction
  • 10.5.5 Takeda Recent Development
• 10.6 Vanda Pharmaceuticals
  • 10.6.1 Vanda Pharmaceuticals Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.6.4 Insomnia Medication Product Introduction
  • 10.6.5 Vanda Pharmaceuticals Recent Development
• 10.7 Astellas
  • 10.7.1 Astellas Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.7.4 Insomnia Medication Product Introduction
  • 10.7.5 Astellas Recent Development
• 10.8 Dainippon Sumitomo
  • 10.8.1 Dainippon Sumitomo Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.8.4 Insomnia Medication Product Introduction
  • 10.8.5 Dainippon Sumitomo Recent Development
• 10.9 ECR Pharmaceuticals (Valeant)
  • 10.9.1 ECR Pharmaceuticals (Valeant) Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.9.4 Insomnia Medication Product Introduction
  • 10.9.5 ECR Pharmaceuticals (Valeant) Recent Development
• 10.10 Flynn Pharma
  • 10.10.1 Flynn Pharma Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Insomnia Medication
  • 10.10.4 Insomnia Medication Product Introduction
  • 10.10.5 Flynn Pharma Recent Development
• 10.11 Johnson & Johnson
• 10.12 Meda
• 10.13 Somnus Therapeutics
• 10.14 Purdue Pharma
• 10.15 Neurim
• 10.16 Minerva Neurosciences
• 10.17 Pernix Therapeutics
• 10.18 SkyePharma
• 10.19 Paratek Pharmaceuticals

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Insomnia Medication Sales Channels
  • 11.2.2 Insomnia Medication Distributors
• 11.3 Insomnia Medication Customers

12 Market Forecast

• 12.1 Global Insomnia Medication Sales and Revenue Forecast 2019-2025
• 12.2 Global Insomnia Medication Sales Forecast by Type
• 12.3 Global Insomnia Medication Sales Forecast by Application
• 12.4 Insomnia Medication Forecast by Regions
  • 12.4.1 Global Insomnia Medication Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Insomnia Medication Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Insomnia Medication is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Insomnia Medication.

This report studies the global market size of Insomnia Medication, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Insomnia Medication sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals

Market Segment by Product Type
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants

Market Segment by Application
Adults
Kids

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Insomnia Medication status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Insomnia Medication manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Insomnia Medication are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025